S
Sironax at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Sironax brings 2 presentations to ObesityWeek 2026 in National Harbor. Its sessions focus on NAMPT activators for obesity. One shows pharmacologic NAMPT activation improving metabolism with weight-lowering effects in DIO mice, and another assesses the carcinogenicity risk of the NAMPT activator SIR4156 using a weight-of-evidence approach.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
S Sironax | |
Biotech developing NAMPT activators, with obesity and metabolic disease among its programs. | Poster Sat Nov 14 7:30pm–8:30pm Pharmacologic NAMPT Activation Improves Metabolism with Weight-Lowering Effects in DIO Mice Metabolism and integrative physiology Poster Sat Nov 14 7:30pm–8:30pm Weight-of-Evidence Carcinogenicity Risk Assessment of the NAMPT Activator SIR4156 in Obesity Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology |
Find decision makers at Sironax
Tell us what you sell and we’ll find the people at Sironax most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction